ABSTRACT
Objective To investigate the effect of Shuxuening intra-articular injection in the treatment of osteoarthritis and its infullence on cytokines in synovial fluid .Methods According to the digital table ,120 patients with osteoarthritis were randomly divided into two groups ,60 cases in each group.The observation group received Shuxuening injection in articular cavity treatment ,and the control group was given sodium hyaluronate .The efficacy and levels of interleukin-1(IL-1) and tumor necrosis factor alpha(TNF-α) in synovial fluid were compared between the two groups.Results After treatment,the score in the observation group was significantly lower than that of the control group(t=16.282,P<0.05).The total effective rate of the observation group was 95.0%,which was signifi-cantly higher than 81.7%of the control group(χ2 =5.175,P<0.05).After treatment,the IL-1βand TNF-αlevels of the observation group were significantly lower than those of the control group (t =4.95,6.656,all P<0.05). Conclusion Shuxuening intra-articular injection in the treatment of osteoarthritis can not only alleviate the symp-toms,improve the curative effect ,but also can reduce the IL-1 βand TNF-αlevels in synovial fluid .
ABSTRACT
Objective To examine the expression levels of cyclin Dl in the patients with chronic myelogenous leukemia (CML), and evaluate the pathogenesis and clinical significance of cyclin Dl in CML Methods The real-time quantitative polymerase chain reaction (RQ-PCR) was performed to detect the expression levels of cyclin Dl in the bone marrow samples of 18 patients with CML, and 16 samples of benign hemopoietic patients. The relationship between the expression levels of cyclin Dl and the progression and prognosis of patients with CML were analyzed. Results The level of cyclin Dl was higher expressed in 18 patients with CML than the control group (P <0.001). The levels of cyclin Dl was apparently higher expressed in accelerated phase /blast crisis phase than in chronic phase (P <0.05). And the RQ-PCR method showed the tendency that a significant increase was observed in the levels of cyclin Dl from 0.1980 in control group to 1.4002 in chronic phase and 5.4540 in accelerated phase /blast crisis phase. Conclusion The cyclin Dl overexpressed in CML, the roles of cyclin Dl in CML might be an oncogene expressed. The expression level is correlated with the progression and prognosis of patients with CML.